Resveratrol reverts Streptozotocin-induced diabetic nephropathy

被引：15

作者：

Zhu, Huiping ^{[1
,2
]}

Zhong, Sen ^{[1
,2
]}

Yan, Haihong ^{[1
,2
]}

Wang, Kangyao ^{[1
,2
]}

Chen, Lingwei ^{[1
,2
]}

Zhou, Min ^{[1
,2
]}

Li, Yunsheng ^{[1
,2
]}

机构：

[1] Wenzhou Med Univ, Peoples Hosp Wenling 1, Dept Nephrol, 333 Chuanan Rd, Wenling 317500, Zhejiang, Peoples R China

[2] Wenzhou Med Univ, Affiliated Wenling Hosp, 333 Chuanan Rd, Wenling 317500, Zhejiang, Peoples R China

来源：

FRONTIERS IN BIOSCIENCE-LANDMARK | 2020年 / 25卷

关键词：

Resveratrol; Renal dysfunction; Diabetic nephropathy; mTOR/ULK1; pathway; Autophagy; RENAL LIPID-METABOLISM; PODOCYTE FUNCTION; AUTOPHAGY; MICE; ACCUMULATION; PROGRESSION; PROTECTS; FIBROSIS; TARGET; MTOR;

D O I：

10.2741/4829

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Diabetes causes diabetic nephropathy (DN) which is associated with increased morbidity and mortality in diabetic patients. We tested whether Resveratrol (Res) reverses the systemic effect of Streptozotocin (STZ) induced diabetes and DN. Res treatment opposed the effect of STZ on kidney weight, 24 h urinary albumin excretion, blood urea nitrogen (BUN) and serum creatinine (Scr). Res also decreased DN induced mTOR/ULK1-mediated autophagy and apoptosis and significantly reduced STZ mediated lipid deposition in nephrons, likely by decreasing the levels of lipogenic related proteins (SREBP-1c, ACS) and increased lipidolysis related proteins (PPAR alpha, CPT-1). Together, these findings show the potential of Res in prevention of diabetic nephropathy.

引用

页码：699 / 709

页数：11

共 50 条

[21] Icariside II ameliorates diabetic nephropathy in streptozotocin-induced diabetic rats
Tian, Wenjie
Lei, Hongen
Guan, Ruili
Xu, Yongde
Li, Huixi
Wang, Lin
Yang, Bicheng
Gao, Zhezhu
Xin, Zhongcheng
DRUG DESIGN DEVELOPMENT AND THERAPY, 2015, 9 : 5147 - 5157
[22] Quercetin liposomes ameliorate streptozotocin-induced diabetic nephropathy in diabetic rats
Tang, Lixia
Li, Ke
Zhang, Yan
Li, Huifang
Li, Ankang
Xu, Yuancheng
Wei, Bing
SCIENTIFIC REPORTS, 2020, 10 (01)
[23] Quercetin liposomes ameliorate streptozotocin-induced diabetic nephropathy in diabetic rats
Lixia Tang
Ke Li
Yan Zhang
Huifang Li
Ankang Li
Yuancheng Xu
Bing Wei
Scientific Reports, 10
[24] Effect of Vitamin E on Diabetic Nephropathy in Streptozotocin-Induced Diabetic Rats
Cobos, David Segura
Salgado, Esperanza Enedina Diaz
Amato, Dante
Garcia, Sinai Ernesto Cardoso
Duque, Tomas Ernesto Villamar
Antunez, Anayantzin Paulina Heredia
Mondragon, Leonardo del Valle
Guerrero, Gil Alfonso Magos
Hernandez, Elizabeth Alejandrina Guzman
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2025, 26 (04)
[25] Effects of imidapril and captopril on streptozotocin-induced diabetic nephropathy in mice
Katoh, M
Ohmachi, Y
Kurosawa, Y
Yoneda, H
Tanaka, N
Narita, H
EUROPEAN JOURNAL OF PHARMACOLOGY, 2000, 398 (03) : 381 - 387
[26] Effect of levosimendan, an inodilator, on streptozotocin-induced diabetic nephropathy in rats
Abdelrahman, Aly M.
Al Salam, Suhail
Al Suleimani, Yousuf
Ashique, Mohamed
Manoj, Priyadarsini
Ali, Badreldin H.
EUROPEAN JOURNAL OF PHARMACOLOGY, 2020, 873
[27] Protective effects of allicin on streptozotocin-induced diabetic nephropathy in rats
Huang, Hong
Jiang, Ying
Mao, Genxiang
Yuan, Fang
Zheng, Hexin
Ruan, Yuan
Wu, Tianfeng
JOURNAL OF THE SCIENCE OF FOOD AND AGRICULTURE, 2017, 97 (04) : 1359 - 1366
[28] Effect of Levosimendan, an Inodilator, on Streptozotocin-Induced Diabetic Nephropathy in Rats
Ali, Badreldin
Al-Salam, Suhail
Al Sulemani, Yousuf
Abdelrahman, Aly
FASEB JOURNAL, 2020, 34
[29] COMBINED EFFECTS OF LEFLUNOMIDE AND BENAZEPRIL IN STREPTOZOTOCIN-INDUCED DIABETIC NEPHROPATHY
Hua, Jin
Guo, Piao Shang
Zhe, Jin Ji
Lan, Zheng Hai
Can, Li
NEPHROLOGY, 2014, 19 : 90 - 90
[30] Renoprotective Effect of Berberine on Streptozotocin-induced Diabetic Nephropathy Rats
Wu, Zhufeng
Xie, Zhanxiong
Liu, Jianghong
Wu, Qunhua
Wang, Xiaokang
INTERNATIONAL JOURNAL OF PHARMACOLOGY, 2017, 13 (03) : 247 - 256

← 1 2 3 4 5 →